Pharmacology & ToxicologyACS Pharmacology & Translational SciencePeer-reviewed
A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for in vivo studies
Andrea Chicca, Daniel Bátora, Christoph Ullmer…·Jürg Gertsch
This paper develops and characterizes RNB-61, a potent and selective CB2R agonist with favorable pharmacokinetics, showing nephroprotective effects in kidney injury models.